Ładuje się......
Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
BACKGROUND: BCL2L13 belongs to the BCL2 super family, with its protein product exhibits capacity of apoptosis-mediating in diversified cell lines. Previous studies have shown that BCL2L13 has functional consequence in several tumor types, including ALL and GBM, however, its function in kidney cancer...
Zapisane w:
| Wydane w: | Cancer Cell Int |
|---|---|
| Główni autorzy: | , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247248/ https://ncbi.nlm.nih.gov/pubmed/34193180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-02039-y |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|